Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of overdose in the synthetic opioid era
Phil Skolnick
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108019-108019
Open Access | Times Cited: 82

Showing 26-50 of 82 citing articles:

Pharmacokinetic Properties of an FDA‐approved Intranasal Nalmefene Formulation for the Treatment of Opioid Overdose
Roger Crystal, Mark J. Ellison, Charlotte Purdon, et al.
Clinical Pharmacology in Drug Development (2023) Vol. 13, Iss. 1, pp. 58-69
Open Access | Times Cited: 11
The pattern of brain oxygen response induced by intravenous fentanyl limits the time window of therapeutic efficacy of naloxone
Carlos M. Curay, Matthew R. Irwin, Eugene A. Kiyatkin
Neuropharmacology (2023) Vol. 231, pp. 109507-109507
Closed Access | Times Cited: 10
Multinational appraisal of the epidemiological distribution of opioid fatalities: a systematic review and meta-analysis
Hope Onohuean, Frasia Oosthuizen
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 3
Fentanyl overdose: Temporal effects and prognostic factors in SKH1 mice
Mackenzie Newman, Cayla Lynch, Heather Connery, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 4, pp. 460-471
Open Access | Times Cited: 3
Pediatric suicide: Review of a preventable tragedy
Donald E. Greydanus, Ahsan Nazeer, Zheala Qayyum, et al.
Disease-a-Month (2024) Vol. 70, Iss. 9, pp. 101725-101725
Closed Access | Times Cited: 3
Oxygen fluctuations in the brain and periphery induced by intravenous fentanyl: effects of dose and drug experience
Shinbe Choi, Michael R. Noya, Eugene A. Kiyatkin
Journal of Neurophysiology (2024) Vol. 132, Iss. 2, pp. 322-334
Closed Access | Times Cited: 3
The placenta as a target of opioid drugs
Cheryl S. Rosenfeld
Biology of Reproduction (2022) Vol. 106, Iss. 4, pp. 676-686
Open Access | Times Cited: 14
Rapid opioid overdose response system technologies
Joseph Tay Wee Teck, Alberto Oteo Pérez, Alex Baldacchino
Current Opinion in Psychiatry (2023) Vol. 36, Iss. 4, pp. 308-315
Open Access | Times Cited: 8
Validation of an analytical method for quantitation of metonitazene and isotonitazene in plasma, blood, urine, liver and brain and application to authentic postmortem casework in New York City
Justine Pardi, Sue Ford, Gail Cooper
Journal of Analytical Toxicology (2023) Vol. 47, Iss. 8, pp. 648-655
Closed Access | Times Cited: 8
Chronic Physical and Vicarious Psychosocial Stress Alter Fentanyl Consumption and Nucleus Accumbens Rho GTPases in Male and Female C57BL/6 Mice
Daniela Franco, Andreas B. Wulff, Mary Kay Lobo, et al.
Frontiers in Behavioral Neuroscience (2022) Vol. 16
Open Access | Times Cited: 13
Has the United States Reached a Plateau in Overdoses Caused by Synthetic Opioids After the Onset of the COVID-19 Pandemic? Examination of Centers for Disease Control and Prevention Data to November 2021
Kate G. Brown, Carina Y. Chen, Deanna Dong, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 13
The paramedic role in caring for people who use illicit and controlled drugs: A scoping review
Jennifer Bolster, Richard Armour, Michelle O’Toole, et al.
Paramedicine (2023) Vol. 20, Iss. 4, pp. 117-127
Open Access | Times Cited: 7
Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest
Céline M. Laffont, Prasad Purohit, Nash Delcamp, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Balancing acts: The dual faces of fentanyl in medicine and public health
Hena Khatoon, Siti Munirah Mohd Faudzi
Legal Medicine (2024) Vol. 71, pp. 102507-102507
Closed Access | Times Cited: 2
Synthetic opioids have disrupted conventional wisdom for treating opioid overdose.
Phil Skolnick, Jordan Paavola, Christian Heidbreder
Drug and Alcohol Dependence Reports (2024) Vol. 12, pp. 100268-100268
Open Access | Times Cited: 2
IUPHAR review: Recent progress in the development of Mu opioid receptor modulators to treat opioid use disorders
Piyusha P. Pagare, Rachael Flammia, Yan Zhang
Pharmacological Research (2023) Vol. 199, pp. 107023-107023
Open Access | Times Cited: 6
Combined treatment with naloxone and the alpha2 adrenoceptor antagonist atipamezole reversed brain hypoxia induced by a fentanyl-xylazine mixture in a rat model
Shinbe Choi, Matthew R. Irwin, Michael R. Noya, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 7, pp. 1104-1112
Closed Access | Times Cited: 6
Ketamine, an Old–New Drug: Uses and Abuses
Katarina Savić Vujović, Ana Jotić, Branislava Medić, et al.
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 16-16
Open Access | Times Cited: 6
A longitudinal study of naloxone opioid overdose awareness and reversal training for first-year medical students: specific elements require reinforcement
Reena K. Sandhu, Michael V. Heller, Jack Buckanavage, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Hippocampal volume loss in individuals with a history of non‐fatal opioid overdose
Dustin R. Todaro, Xinyi Li, Laís S. Pereira‐Rufino, et al.
Addiction Biology (2023) Vol. 28, Iss. 10
Open Access | Times Cited: 4
American College of Medical Toxicology and the American Academy of Clinical Toxicology position statement: nalmefene should not replace naloxone as the primary opioid antidote at this time
Andrew Stolbach, Maryann Mazer‐Amirshahi, Lewis S. Nelson, et al.
Clinical Toxicology (2023) Vol. 61, Iss. 11, pp. 952-955
Open Access | Times Cited: 4
“Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose
Aurélie Aquizerate, Morgane Rousselet, Axel Cochard, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Comment on: Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?
Phil Skolnick
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 3, pp. 317-318
Open Access | Times Cited: 1
A Single Ascending-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Respiratory Stimulant ENA-001
Joseph V. Pergolizzi, Thomas L. Miller, Jeanette Mathews, et al.
Cureus (2024)
Open Access | Times Cited: 1
Overview of approved psychiatric medications 2008-2023: A systematic review
Waguih William IsHak, Jayant Totlani, Nathalie Murphy, et al.
World Journal of Advanced Research and Reviews (2024) Vol. 21, Iss. 3, pp. 885-915
Open Access | Times Cited: 1

Scroll to top